GDRX — Goodrx Holdings Income Statement
0.000.00%
Last trade - 00:00
- $2.64bn
- $2.63bn
- $750.27m
- 91
- 19
- 92
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 388 | 551 | 745 | 767 | 750 |
Cost of Revenue | |||||
Gross Profit | 374 | 521 | 699 | 701 | 683 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 253 | 826 | 732 | 765 | 781 |
Operating Profit | 135 | -276 | 13.4 | 1.74 | -31 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 83 | -303 | -10.2 | -23.2 | -55.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 66 | -294 | -25.3 | -32.8 | -8.87 |
Net Income Before Extraordinary Items | |||||
Net Income | 66 | -294 | -25.3 | -32.8 | -8.87 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 66 | -294 | -25.3 | -32.8 | -8.87 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.182 | -1.07 | -0.039 | -0.024 | 0.049 |
Dividends per Share |